Objectives-To show molecular similarity between two sequences ofProteus mirabilis (haemolysin-ESRRAL; urease-IRRET) with HLA-DR antigens (EQRRAA) which are associated with rheumatoid arthritis (RA) and type XI collagen (LRREI), respectively; and, in patients with RA, to measure levels of antibody against a 16-mer synthetic peptide containing the ESRRAL sequence, and the haemolysin and urease proteins ofProteus mirabilis. Methods-The homologous sequences EQRRAA and ESRRAL were modelied with Alchemy III, using the crystalline structure of DRBl*0101 (HLA-DRl).
Sera from 40 patients with RA, 30 with ankylosing spondylitis (AS), and 30 controls were tested against synthetic ESRRAL peptide and the haemolysin of Proteus mirabilis by enzyme linked immunosorbent assay. Similar tests were also carried out on sera from 20 patients with RA, 40 with AS, and 15 controls, against Proteus mirabilis urease. Results-Molecular modelling of the homologous sequences ESRRAIJEQRRAA and IRRET/LRREI showed stereochemical similarities. Antibodies to the 16-mer synthetic peptide containing the ESRRAL sequence, the haemolysin, and urease proteins were significantly increased in RA patients compared with AS patients (p < 0.001) and healthy controls (p < 0.001).
No such increases were observed with three control peptides including the EDERAA sequence of DRB1*0402 (HLA-DR4/Dw1O), the haemolysin proteins of Streptococcus pyogenes and Vibrio parahaemolyticus, and the urease of Bacillus pasteurii.
Conclusion-The additive effect of the immune responses to the two Proteus mirabilis antigens, haemolysin (ESRRAL) and urease (IRRET), could be relevant in the aetiopathogenesis of RA.
(Ann Rheum Dis 1995; 54: [216] [217] [218] [219] [220] The association between rheumatoid arthritis (RA) and some subtypes of HLA-DR4 is well established:' a particular region of the DR3 1 chain, from position 70-74, encoding amino acids Gln-Arg-Arg-Ala-Ala (QRRAA) and found in DRBl*0101 (DR1) and DR4 (subtypes DRB1*0404 (Dw14) and DRBl*0405 (Dw15)), has been identified as the molecular sequence responsible for susceptibility to RA.2 The sequence closely resembles that found in DRB 1*0401 (DR4/Dw4) individuals, there being only one conservative substitution at position 71, from arginine to lysine (QKRAA); glutamic acid (E) occupying position 69 is common to all DR, 1 molecules. Furthermore, the EQRRAA sequence is also found in DRB1*1402 (DR6/Dw16) positive Yakima Indians with RA. Our group has reported an amino acid homology between an outer membrane haemolysin protein of Proteus mirabilis and the susceptibility sequence in HLA-DR1 and DR4 subtypes associated with RA.3 Because RA is a systemic disorder and cartilage destruction is a major feature of the disease, a search of the protein database was made for any sequence homology between Proteus mirabilis and collagen. An amino acid homology was identified between Proteus mirabilis urease (IRRET), amino acid residues 337-3414 and o2(XI) collagen (LRREI) residues 421-425.5 Type XI collagen is a component of hyaline cartilage which is composed of three different polypeptide subunits aol(XI), a2(XI), ot3(XI). Early studies from our laboratory showed that anti-HLA-DR4 tissue typing sera bound significantly to Proteus mirabilis compared with non-DR4 tissue typing sera; no such interaction was found with Escherichia coli.6 In addition, we have reported an increase in Proteus antibodies in RA patients7 which has been confirmed by two independent groups, from Dublin8 and Newcastle.9 The hexamer sequence ESRRAL and the pentamer IRRET of Proteus mirabilis are both hydrophilic, which suggests that they may be immunogenic. In the second study (antibodies against the urease protein), patients and controls were different from those in the first study. They comprised 20 patients with RA (five male/ 15 female; mean age 56 (20-75) years; mean ESR 59-8 (7 7) mmllst h), 40 AS patients (29 males/i1 females; mean age 45 (21-76) years; mean ESR 25-9 (3-6) mm/lst h), and 15 healthy control subjects (mean age 29 (21-52) years). MOLECULAR 
MODELLING
Comparison of space filling models of a predicted ESRRAL sequence of Proteus haemolysin and EQRRAA sequence within DRB1*0101 (HLA-DR1) from known crystallographic structure was carried out to study spatial configuration. The ESRRAL model was constructed as a helix with torsional angles corresponding to those observed in the known EQRRAA sequence and the two sequences were superimposed (root mean square (RMS) = 0 046). The ESRRAL and EQRRAA sequences were also compared with the sequence EDERAA, present in DRB1*0402 (HLA-DR4/Dw10), which is not associated with RA.
Comparison of space filling models was made of the predicted IRRET of Proteus mirabilis urease and LRREI of ot2(XI) collagen. Both sequences were constructed as helices and the two sequences were superimposed (RMS = 0-0 11). Structures were modelled using Alchemy III (Tripos ASSOC Inc, St Louis, USA).
ELISA STUDIES WITH SYNTHETIC PEPTIDES
Peptides were prepared by solid phase synthesis and analysed for purity by high performance liquid chromatography. The test peptide was LGSISESRRALQDSQR (1 6-mer), which represents amino acid residues 27-42 of Proteus mirabilis haemolysin (hpm B);10 three control peptides, SQKDILEDERAAVDTY (16-mer) DRB1*0402 (HLA-DR4/Dw1O), YASGASGAS (9-mer), and DAHKSEVAHRFLDLGEENFKALVL (24-mer), were used to exclude non-specific binding. Sera were tested against the Proteus mirabilis haemolysin peptide and control peptides by enzyme linked immunosorbent assay (ELISA). Briefly, polystyrene microtitre plates (Dynatech, Billingshurst, UK) were coated with the synthetic peptide (5 0 ,ug/well) overnight at 4°C. After absorption and washing with phosphate buffered saline (PBS)-Tween, the plates were saturated with 1% bovine serum albumin (BSA)-PBS-Tween and incubated for one hour at 37°C, followed by further washing with PBS-Tween. Serum samples (200 RI at 1/50 dilution in PBSTween) were added and the plates incubated for 90 minutes at 37°C, followed by washing with PBS-Tween. Peroxidase conjugated rabbit anti-human class specific IgG, IgA or IgM (DAKO Ltd, Bucks, UK) diluted 1/500 in PBS-Tween was added and the plates incubated for 90 minutes at 37°C then washed. 
Results
Molecular modelling of the two structures ESRRAL and EQRRAA showed a common surface of homologous residues. The positions 32, 34, 35 and 69, 71, 72 form a motif common to HLA-DR and Proteus mirabilis occupying the same stereochemical space. However, the EDERAA sequence of DRB 1*0402 (HLA-DR4/Dw10) which is not associated with RA, differed from both the ESRRAL and EQRRAA motifs (fig 1) . Molecular modelling of the two sequences IRRET and LRREI also showed a common surface of homologous residues. The positions 338, 339, 340 and 421, 422, 423, form a motif common to type XI collagen and Proteus mirabilis urease occupying the same stereochemical space (fig 1) . The common surface of homologous residues observed in the sequences ESRRAIIEQRRAA and IRRET/LRREI, which may be involved in immune interactions, consists of two positively charged arginines and one negatively charged glutamic acid.
Antibodies to Proteus mirabilis haemolysin peptide LGSISESRRALQDSQR of the IgG class were significantly increased in RA patients (mean 0-263 (SE 0-011) OD units) compared with AS patients (0-162 (0-012) OD units) (t= 5-98, p < 0001) and healthy controls (0K158 (0-014) OD units (95% confidence limits (CL) of mean ±0 026) (t= 5 90, p < 0-001) (fig 2) . The difference between the titres in AS patients and healthy controls tested against the haemolysin peptide was not (fig 3) . 
